— As the technology measures the DNA and not the vector, it can be deployed to screen multiple pathogens
MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ — Based on its recent analysis of the methillicin-resistant Staphylococcus aureus (MRSA) screening market, Frost & Sullivan recognizes F Cubed, LLC. with the 2014 North America Frost & Sullivan Award for Technology Innovation Leadership. F Cubed’s portable device, the NESDEP IU, can rapidly and cost-effectively screen patients suspected of having contracted MRSA. This screening tool can help eliminate unwanted side effects, time, anxiety, and the huge costs associated with the treatment of MRSA.
The NESDEP IU can be operated by laymen with minimal staff training The device operates on a biochip that measures 7 millimeters (mm) by 14 mm and comprises nano-scale electrodes and microfluidic structures that contain a mix of carbon nanotubes characterized to hybridize with very specific DNA molecules.
Importantly, the NESDEP IU and its associated screening test are 10 times less expensive than competing medical equipment in the market. The NESDEP IU can screen a MRSA-suspect patient within two hours, thereby accelerating the delivery of an appropriate treatment.
"The device is highly durable and portable, and comes in a durable MIL-SPEC plastic case with wheels. It weighs approximately 35 kg and can fit on a 3-foot table top," said Frost & Sullivan Saju Mathew, Industry Analyst. "In the future, F Cubed plans to integrate several biochips into the system to enable the simultaneous detection of a wider range of pathogens."
Apart from being applied for the rapid identification of pathogenic bacteria in medical diagnostics, F Cubed uses the NESDEP IU in food safety and environmental science applications as well. It is also looking into pathogens such as E. coli, Listeria, and Salmonella due to the recent passage of the Food Safety Modernization Act in 2011. As the regulatory hurdles in the food safety industry are not as stringent as in the medical diagnostics industry, Frost & Sullivan expects strong traction for F Cubed in this segment.
"F Cubed’s technology rests on exclusive licenses obtained from the University of Notre Dame (Notre Dame, Indiana) and the Technion-Israel Institute of Technology," noted Saju Mathew. "Through careful, strategic patent planning, F Cubed has isolated critical features and pursued strategies that are most likely to protect the company’s value."
Furthermore, to ensure an efficient and healthy relationship with its customers, initially, F Cubed will only serve those regions where service personnel are only a day’s drive away from the customer’s location. The low requirements for device functioning and maintenance are allowing F Cubed to consider penetrating countries with inadequate resources, infrastructure, or trained medical staff.
The company’s technology will truly go a long way in saving lives as well as ensuring safer food and water. For these important technological advances, Frost & Sullivan is proud to present the 2014 North America Frost & Sullivan Award for Technology Innovation Leadership to F Cubed.
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spent toward innovation, its relevance to the industry and the positive impact on brand perception.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About F Cubed LLC
F Cubed LLC was founded in 2010 in South Bend, Indiana to create a molecular diagnostic method taking a raw sample to a full assay in less than two hours. The company licensed the AC Dielectrophoretic technology from the University of Notre Dame. F Cubed is divided into three separate companies, Food Safety, Environmental and Medical. Tests have been developed to detect MRSA, lymphatic filariasis, E.coli, listeria and salmonella. Future tests include cryptosporidium, C.difficile, enterococcus and campylobacter.
Trials for water testing are set to begin with the City of South Bend Water Treatment Facility, food testing with Purdue University and FDA 510K trials with 4 U.S. hospitals.
For more information, visit www.fcubed.biz.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?